人肝癌细胞的IGF—BP1分子特性及内源性蛋白酶对其降解的研究

用ＳＤＳ－ＰＡＧＥ电泳、高效液相色谱（ＨＰＬＣ）、质谱等方法,研究了人肝癌细胞（ＨｅｐＧ２）分泌的胰岛素样生长因子结合蛋白－１（＾３５Ｓ－ＩＧＦ－ＢＰ１）的分子结构、特性,及其被内源性蛋白酶降解的特点,＾３５Ｓ－ＩＧＦ－ＢＰ１的经抗体免疫沉淀、生化分离,纯化为均一体,其分子是由多个亚构成的蛋白质,分子量约为２７ｋＤ;细胞ＵＭＲ、ＨｅｐＧ２、Ｈ３５ＢＲＬ３Ａ分泌的蛋白酶能将＾３５Ｓ－ＩＧＦ－ＢＰ１催     

EB病毒转化Hu—TLC—SCID小鼠脾细胞的实验研究

利用ＥＢ病毒转化可产生较高水平人ＩｇＧ和特异性抗２型登革病毒人抗体的Ｈｕ－ＴＬＣ－ＳＣＩＤ小鼠脾细胞,通过免疫组化、免疫荧光和ＰＣＲ法检测转化细胞的人Ｂ细胞表面标志、ＥＢ病毒抗原和ＥＢ病毒基因。结果表明,被团体的Ｈｕ－ＴＬＣ－ＳＣＩＤ小鼠脾细胞能继续产生抗２型登革病毒的特异性人抗体,并具有人Ｂ细胞的ＣＤ２０＾＋、ＳｍＩｇＧ标志及ＥＢ病毒潜伏膜蛋白－１（ＬＭＰ－１）基因,可表达ＬＭＰ－１和ＥＢ病毒核     

蜈蚣碱性蛋白SSmp—d的分离纯化及其部分理化性质的鉴定

少棘巨蜈蚣经９５％乙醇脱脂后,再经４℃水冷渗,水提液低温旋转浓缩,冻干,得到的冻干粉先后经过Ｓｅｐｈａｄｅｘ Ｇ－２５柱,等电聚焦制备电泳,再经Ｓｅｐｈａｄｅｘ Ｇ－１５０柱,Ｓｅｐｈａｄｅｘ Ｇ－１００柱,最后经ＨＰＬＣ制备得到一个纯的碱性蛋白,命名为ＳＳｍｐ－ｄ。该蛋白经ＨＰＬＣ、超薄等电聚焦电泳检验是均一的。采用ＨＰＬＣ和Ｐｒｏｔｅｉｎ－Ｐａｋ＾ＴＭ１２５柱测定其分子量为２４．６４ｋＤ。ＩＥ     

乙型肝炎病毒表面抗原S和前S1融合基因转基因细胞系的建立与细胞性质的研究

构建了ｐＣＨＢＳＳＩＧ质料,其特点是ＣＭＶ立即早期启动子调控乙型肝炎（乙肝）表面抗原Ｓ＋前Ｓ１融合基因在前,ＳＶ４０早期启动子调控ＧＳ扩增基因在后,此质粒转化到ＣＨＯ－ｄｈｆｒ＾－细胞中,经克隆加ＭＳＸ及ＭＴＸ筛选、扩增,建立了７个高效表达乙肝表达抗原Ｓ及前Ｓ１融合蛋白细胞系ＧｄＳＳ１,并检测了其中ＧｄＳＳ１－１８细胞系的生物学特性,结果表明：未发现微生物污染,无致瘤性、遗传稳定,电镜下可观察到２     

干旱胁迫对黄瓜PSⅡ颗粒铁组分Mossbauer谱的影响

黄瓜（Ｇｃｕｍｉｓ ｓａｔｉｖｕｓ Ｌ）叶片ＰＳⅡ颗粒的Ｍｏｓｓｂａｕｅｒ谱呈现４套双峰,依它们的化学位移相四敬矩劈塑数值,分别属于氧化态Ｃｙｔ－ｂ５５９,还原态Ｃｙｌ－ｂ５５９、Ｆｅ＾３＋－Ｑ画物和Ｆｅ＾２＋－Ｑ复合物。干埋胁迫旱影响ＱＡ／ＱＢ中铁（Ｆｅ）参与电子传递的速率,使ＰＳⅡ颗粒的ｏｓｓｂａｕｅｔ谱中Ｆｅ＾２＋的吸收双峰消失,即还原态Ｇ７ｙｔ－Ｂ５５９转变为氧化态Ｃｙｔ－ｂ５５９Ｆｅ＾２     

甲基单胞菌Methylomonassp.GYJ3中甲烷单加氧酶还原酶组分的…

Ｍｅｙｌｏｍｏｎａｓ ｓｐ．ＧＹＪ３菌的甲烷单加氧酶（ＭＭＯ）粗酶提取液经ＤＥＡＥ－Ｓｅｐｈａｒｏｓｅ ＣＬ－６Ｂ阴离子交换层析,Ｓｅｐｈａｄｅｘ Ｇ－１００凝胶过滤层析和ＤＥＡＥ－ＴＳＫｇｅｌ ＨＰＬＣ分离纯化出ＭＭＯ还原酶组分,经ＨＰＬＣ分析,纯度大于９５％,纯化倍数为４．４,加入至ＭＭＯ羟基化酶和调节蛋白Ｂ的体系中表现比活为２２８ｎｍｏｌ环氧丙烷每分钟毫克蛋白,ＳＤＳ－ＰＡＧＥ电泳表明的酶由     

硫酸乙酰肝素蛋白聚糖对培养人脐静脉内皮细胞合成蛋白聚糖的…

以「＾３５Ｓ」－Ｎａ２ＳＯ４为示踪物,观察人正常主动脉中的硫酸乙酰肝素蛋白聚糖（ＨＳＰＧ）对培养的第一代人脐静脉内皮细胞（ｈＵＶＥＣ）合成蛋白聚糖（ＰＧ）的影响,用解聚提取法及离子交换柱层析分离人主动脉ＨＳＰＧ,＾３５Ｓ－ＰＧｓ的混合物用离子交换及凝胶过滤柱层析法分离＾３５Ｓ－ＨＳＰＧ,＾３５Ｓ－硫酸软骨素－硫酸皮肤素ＰＧ（＾３５Ｓ－ＣＳＤＳＰＧ）及＾３５Ｓ－硫酸皮肤素ＰＧ（＾３５Ｓ－ＤＳＰＧ）,     

外源钙调素对粟酒裂殖酵母细胞增殖的影响

外源钙调素（ＣａＭ）对粟酒裂殖酵母（Ｓｃｈｉｚｏｓａｃｃｈａｒｏｍｙｃｅｓ ｐｏｍｂｅ）细胞增殖的影响。实验结果表明外源ＣａＭ能明显抑制粟酒裂殖酵母细胞的增殖,其作用方式是延长了粟酒裂殖酵母细胞生长的延滞期,抗粟酒裂殖酵母ＣａＭ抗体,ＴＦＰ及Ｐｈｅｎｙｌ－ＳｅｐｈａｒｏｓｅＣＬ－４Ｂ能降低ＣａＭ对细胞生长的抑制作用,而Ｃａ＾２＋及Ｃａ＾２＋螯合剂ＥＧＴＡ对ＣａＭ的抑制作用均无影响。以上结果提示,外     

细胞松驰素B促微丝解聚对DNA合成的作用

利用微丝（ｍｉｃｒｏｆｉｌａｍｅｎｔ,ＭＦ）解聚药物细胞松驰素Ｂ（ｃｙｔｏｃｈａｌａｓｉｎＢ,ＣＢ）处理Ｇ_０期小鼠Ｃ_３Ｈ_（１０）Ｔ_（１／２）成纤维细胞,对Ｇ_０至Ｓ期ＤＮＡ合成,胸腺嘧啶核苷激酶（ｔｈｙｍｉｄｉｎｅｋｉｎａｓｅ,ＴＫ）活性、ＴＫ基因表达、钙调素（ｃａｌｍｏｄｕｌｉｎ,ＣａＭ）水平和一些细胞周期早期基因的表达进行了观察,Ｇ_０期细胞经３ｍｇ／ＬＣＢ处理２ｈ,促ＭＦ解聚增强了血清对Ｓ期细胞ＴＫ活性、ＴＫ基因表达和ＤＮＡ合成的刺激作用,并促进细胞提前进入Ｓ期．血清刺激Ｇ_０期细胞进入晚Ｇ_１期和Ｓ期时,ＣａＭ水平明显升高,而ＣＢ预处理则使ＣａＭ含量进一步增加,特别是ＣＢ处理促使Ｓ期ＣａＭ增加向核内转移．ＣＢ处理明显增强血清对ｃ－ｊｕｎ、ｃ－ｆｏｓ和ｃ－ｍｙｃ基因表达的刺激作用,而ＰＫＣ抑制剂Ｈ_７则抑制ＣＢ处理对这些基因转录的刺激作用,说明ＣＢ使Ｇ_０期细胞ＭＦ解聚刺激ｃ－ｊｕｎ、ｃ－ｆｏｓ和ｃ－ｍｙｃ的转录活性与ＰＫＣ的作用有关．结果表明Ｇ_０至Ｓ期早期ＭＦ的重组可促进细胞进入Ｓ期,增强ＤＮＡ合成．     

DDPH对猪肺动脉平滑肌细胞PDGF·BB和bFGF表达的影响：免疫细胞化学研究

ＤＤＰＨ［１－（２．６－二甲基苯乙氧基）－２－（３．４二甲氧基苯乙胺基）丙烷盐酸盐］是南京药科大学合成的降压新化合物,也具有降低肺动脉高压和抑制肺动脉平滑肌细胞增殖作用。本实验用细胞培养、免疫细胞化学、图像分析、３Ｈ－ＴｄＲ、细胞周期测定等方法,进一步探讨ＤＤＰＨ对缺氧性肺动脉平滑肌细胞（ＰＡＳＭＣＳ）增殖的抑制机制。结果：缺氧促进肺动脉内皮细胞（ＰＡＥＣｓ）的ＰＤＧＦ·ＢＢ和ｂＦＧＦ两种生长因子的表达（积分光密度ＯＤ值）增高。缺氧内皮细胞条件培养液（ＨＥＣＣＭ）能促进ＰＡＳＭＣＳ的ＰＤＧＦ·ＢＢ的ＯＤ值增高,ｂＦＧＦ的ＯＤ值无明显改变。加药组（ＨＥＣ－ＣＭ＋ＤＤＰＨ）的ＰＤＧＦ·ＢＢ和ｂＦＧＦ的ＯＤ值均显著降低,尤以ＰＤＧＦ·ＢＢ的ＯＤ值减少最多．提示：ＤＤＰＨ能抑制ＨＥＣＣＭ引起ＰＡＳＭＣＳ的ＰＤＧＦ·ＢＢ和ｂＦＧＦ表达增多和细胞增殖。结果与大鼠实验观察相符。     

Preliminary characterisation of locust diuretic peptide (DP-1) and another corpus cardiacum peptide (LCCP)

A simple two step HPLC purification protocol is described for one of the locust diuretic peptides (DP-1) and a second corpus cardiacum peptide (LCCP) of unknown function. DP-1 and LCCP are extracted from corpora cardiaca in 20% aqueous methanol (v/v), and applied to a high performance size-exclusion chromatography (HPSEC) column, from which DP-1 and LCCP co-elute in a fraction designated F7/8; this corresponds to a relative molecular mass of ca 6000–7000. Without sample concentration, F7/8 (2 ml) is applied directly onto a wide-pore reversed-phase HPLC column; LCCP and DP-1 are eluted in ca 12 and 20 min respectively on an increasing linear gradient of 0.5% min, starting at 30% acetonitrile. The diuretic activity of the DP-1 material was confirmed using the cAMP assay (Morgan and Mordue, 1985a, Insect Biochem.15, 247–257).DP-1 and LCCP were isolated from ca 650 locusts using the above procedures for sequence analysis by gas-phase sequencing. The low amount of DP-1 purified allowed only a partial and fragmentary sequence to be determined; insufficient material was available for amino acid analysis. The higher amount of LCCP allowed a partial sequence determination of residues 1–40. The titre of DP-1 in locust CC is calculated to be 1.7–2.1 pmol/CC.     

Membrane interactions and metal ion effects on bilayer permeation of the lipophilic ion modulator DP-109

DP-109, a lipophilic bivalent metal ion modulator currently under preclinical development for neurodegenerative disorders, was designed to have membrane-associated activity, thereby restricting its action to the vicinity of cell membranes. We describe the application of a colorimetric phospholipid/polydiacetylene (PDA) biomimetic membrane assay in elucidating DP-109 membrane interactions and penetration into lipid bilayers. In this membrane model, visible quantifiable color changes were monitored in studying membrane interactions. The colorimetric data identified a biphasic concentration-dependent interaction, with a break point around the critical micelle concentration (CMC) of DP-109. The kinetics and colorimetric dose-response profile of DP-109 indicate that the compound inserts into the lipid bilayers rather than being localized at the bilayer surface. Analysis of interactions of DP-109 with phospholipid/PDA vesicles in which ionic gradients were imposed indicates that membrane activity of DP-109 is strongly affected by electrochemical gradients imposed by K+ and Zn2+. The ionic gradient effects suggest that the insertion of DP-109 into the membrane may depend on the membrane potential.     

E2F-1 regulation by an unusual DNA damage-responsive DP partner subunit

E2F activity is negatively regulated by retinoblastoma protein (pRb) through binding to the E2F-1 subunit. Within the E2F heterodimer, DP proteins are E2F partner subunits that allow proper cell cycle progression. In contrast to the other DP proteins, the newest member of the family, DP-4, downregulates E2F activity. In this study we report an unexpected role for DP-4 in regulating E2F-1 activity during the DNA damage response. Specifically, DP-4 is induced in DNA-damaged cells, upon which it binds to E2F-1 as a non-DNA-binding E2F-1/DP-4 complex. Consequently, depleting DP-4 in cells re-instates E2F-1 activity that coincides with increased levels of chromatin-bound E2F-1, E2F-1 target gene expression and associated apoptosis. Mutational analysis of DP-4 highlighted a C-terminal region, outside the DNA-binding domain, required for the negative control of E2F-1 activity. Our results define a new pathway, which acts independently of pRb and through a biochemically distinct mechanism, involved in negative regulation of E2F-1 activity.     

Identification of significant regions of transcription factor DP-1 (TFDP-1) involved in stability/instability of the protein

We previously reported the identification of DP-1 isoforms (α and β), which are structurally C-terminus-deleted ones, and revealed the low-level expression of these isoforms. It is known that wild-type DP-1 is degraded by the ubiquitin-proteasome system, but few details are known about the domains concerned with the protein stability/instability for the proteolysis of these DP-1 isoforms. Here we identified the domains responsible for the stability/instability of DP-1. Especially, the DP-1 “Stabilon” domain was a C-terminal acidic motif and was quite important for DP-1 stability. Moreover, we propose that this DP-1 Stabilon may be useful for the stability of other nuclear proteins when fused to them.     

Effects of DP-1904, a thromboxane synthetase inhibitor, on the antigen-induced airway hyperresponsiveness and infiltration of inflammatory cells in guinea-pigs

The effect of DP-1904, a novel thromboxane (TX) synthetase inhibitor, on airway hyperresponsiveness was studied in actively sensitized guinea-pigs. Airway hyperresponsiveness to intravenous ACh was observed at 3 and 7 h after aerosolized antigen challenge. In the model, a significant correlation between increases of respiratory resistance and microvascular leakage was observed, corresponding to the elevation of TXB2 in bronchoalveolar lavage fluid (BALF) in the early phase. DP-1904, at doses of 3 mg/kg or higher given orally one hour prior to the antigen challenge, inhibited the TXB2 production and the development of airway hyperresponsiveness in the early phase. Further, DP-1904 significantly suppressed the accumulation of lymphocytes in BALF and airway hyperresponsiveness in the late phase, although it only slightly decreased the mobilization of eosinophils and neutrophils. The results suggest that TXA2 is possibly involved in the development of airway hyperresponsiveness, and DP-1904 prevented the airway hyperresponsiveness via inhibition of TXA2 production and regulation of inflammatory cells.     

Effects of hexapeptide, a compound analogous to insulin B chain fragment B-21-26(DP-432) on the glucose uptake into the perfused hind limb of rats

DP-432 is a synthetic new peptide analogous to insulin B-chain fragment B21-26. It has been reported that this hexapeptide shows insulin potentiating action besides insulin-like activities in adipose tissue and diaphragm of rats. The perfusion of the hind limb of rats was performed according to the procedure of Ruderman with some modifications. The medium was Krebs-Ringer bicarbonate buffer containing 0.5% bovine albumin and 8.3 mM glucose. The erythrocytes were omitted from the medium. In this experimental procedure it was shown that the glucose uptake into the hind limb of rats increased by infusion of DP-432 (100 microgram/ml). The amount of glucose uptake into the hind limb responded to insulin doses (50, 100, 1000 muU/ml). DP-432 had insulin-like activity of 100 muU/ml. However, DP-432 itself did not have any potentiation of insulin activity on the muscle.